InvestorsObserver
×
News Home

Is 89bio Inc (ETNB) a Winner in the Healthcare Sector?

Wednesday, March 29, 2023 12:23 PM | InvestorsObserver Analysts

Mentioned in this article

Is 89bio Inc (ETNB) a Winner in the Healthcare Sector?

89bio Inc (ETNB) is around the top of the Healthcare sector according to InvestorsObserver. ETNB received an overall rating of 100, which means that it scores higher than 100% of stocks. Additionally, 89bio Inc scored a 100 in the Healthcare sector, ranking it higher than 100% of stocks in that sector.

Overall Score - 100
ETNB has an Overall Score of 100. Find out what this means to you and get the rest of the rankings on ETNB!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 100 means the stock is more attractive than 100 percent of stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With 89bio Inc Stock Today?

89bio Inc (ETNB) stock is lower by -5.39% while the S&P 500 has gained 1.1% as of 12:09 PM on Wednesday, Mar 29. ETNB is lower by -$0.90 from the previous closing price of $16.69 on volume of 789,808 shares. Over the past year the S&P 500 is lower by -13.31% while ETNB has gained 321.07%. ETNB lost -$2.93 per share the over the last 12 months. Click Here to get the full Stock Report for 89bio Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App